Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Well initiates ‘business continuity plans’ as crane issues affect capacity

Well Pharmacy will stop using three cranes at its Stoke-on-Trent healthcare service centre until 2023 after identifying “structural weaknesses”, it has told C+D.

The multiple uncovered structural issues in three out of the six cranes it operates at its Stoke-on-Trent healthcare service centre during a “regular check”, a Well spokesperson told C+D yesterday (December 1).

It therefore chose “to temporarily decommission them to protect the safety of [its] workforce”.

The site typically moves “millions of units every week”, the spokesperson explained.

Repairs of the cranes are likely to last “until sometime in the New Year”, the Well spokesperson added.

“Unfortunately, this has impacted on our ability to operate at full capacity at our healthcare service centre,” they went on to say.

However, the multiple has initiated “business continuity plans” in the meantime, which it says “will ensure impacts to [its] patients and customers is minimised”.

“We will continue to provide a full business as usual operation,” the spokesperson said.

Read more: Well blames flat pharmacy funding as it outsources office roles abroad


No drop in productivity

 

The spokesperson emphasised that half of Well’s cranes “being out of action temporarily does not result in a 50% reduction in service”.

The site will not experience “a drop in productivity” while the three cranes are being repaired, they added.

Last week, Well told C+D it will move “some” support office functions to a sister company outside of the UK, blaming “steeply rising costs due to inflation”.

The multiple is also seeking to grow its pharmacy workforce, offering overseas pharmacists a support package worth up to £8,000 as well as “bespoke training”.

Related Content

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD136588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel